![]() Press Release Distribution |
Filter News Show All ResultsNews By Country
News By Tag Virus ![]() Related Tags Computer
Cure Fix Gene-Eden VIR Help How Infection Latent Virus Malware Natural Remedy Removal Remove Repair Security Spyware Technology To Tutorial Viruses
| virus News+ XML/RSSBy Simon Campbell The organization would like to highlight the research that is being done in the world of alternative medicine. By Howard Schwartz As the popularity of e-readers and e-books grows, so does the proliferation of related scams. By Brighton Publishing Brighton Publishing LLC announced the eBook release of debut author’s highly-anticipated, controversial bio-thriller By Cochrane & Associates, LLC The environmental and infection control professionals at Clark Seif Clark (CSC) provide services to help prevent outbreaks of norovirus. By Cochrane & Associates, LLC Sussex Environmental Health Consultants facilitate averting and identifying sources infectious outbreaks. By Kingsoft New BIOS based virus, BMW, wildly spreads for downloading malicious viruses, Trojan and other malicious to infected local computer and, remote control local devices for malicious outbound behaviors. By Kevin Abbott RebootThat.com awarded Microsoft Small Business Specialist status. By completing highly technical exams enabling us to help start up and small-to-medium businesses with 5 or more PCs, tackle their business challenges through IT solutions. By Cochrane & Associates, LLC The IAQ Video Network produces another educational video about the health effects of exposure to environmental hazards. By Hackney Communications Small businesses will have access to comprehensive and affordable computer maintenance, monitoring, security, and backup services By EC2, Inc. EC2 helps medical facilities with infection control services to help prevent these costly and sometimes deadly infections. All Press ReleasesBy Simon Campbell The CBCD learned that a new study from the Mayo Clinic states that one factor associated with fibromyalgia symptoms is a patient's weight. By Simon Campbell The CBCD just learned that Medivir AB has announced that its cold sore product Xerclear®, is being launched for over-the-counter use by its partner GlaxoSmithKline in Europe. By Simon Campbell Scientists from MIT, Rockefeller University and the Medical College of Wisconsin have found a technique to generate liver-like cells made from stem cells. By Simon Campbell The Virginia House of Delegates has voted to repeal the law requiring girls to receive the human papillomavirus vaccine. By Simon Campbell A new study on the Epstein Barr virus (EBV) and Multiple Sclerosis (MS) suggests that the association may be more complicated than thought. By Simon Campbell The Center for the Biology of Chronic Disease (CBCD) wishes to use the experience of certain celebrities to educate the public about the dormant Herpes virus. By Simon Campbell Two companies have made a deal with each other that will allow Veregen®, a cream against Genital Warts, to be sold within Turkish borders. By Simon Campbell According to the CDC the highest rate of advanced cervical cancer occurs among Latina women between 50 and 79 years of age. By Cochrane & Associates, LLC UltraViolet Devices, Inc. (UVDI) recognizes two decades of UV and molecular filtration technological advancements and success. By Simon Campbell A recent study found that 72% of physicians don’t know that the HPV vaccine protects against anal cancer. By Simon Campbell Evidence of retroviruses and herpes viruses has been found in illegally imported wildlife meat products. By Simon Campbell The National Institutes of Health (NIH) scientists have developed a new way to see structures within viruses. By Simon Campbell The cause of Multiple Sclerosis (MS) may be the Epstein Barr Virus (EBV). This is according to a new study published in the scientific journal, “Neurology.” By Simon Campbell The New England Journal of Medicine has published the results of a study sure to disappoint those hoping for a breakthrough vaccine against Genital Herpes. By Simon Campbell Merck Pharmaceuticals announced that it was planning on “making whatever deals are necessary” to make sure the company maintains its lead in developing and manufacturing oral medications to treat the Hepatitis C virus. By Simon Campbell The CBCD has learned that treatment of herpes simplex virus type 2 in patients coinfected with herpes and HIV-1 could postpone the progression of HIV. By Simon Campbell The Epstein Barr virus may cause Multiple Sclerosis according to an article published in MedPage Today. By Simon Campbell A paper published ahead of print in the Journal of Infectious Diseases says that Chronic Hepatitis B virus (HBV) infection almost doubles the risk of AIDS or death in people diagnosed with HIV infection. By Simon Campbell The CBCD believes that hard research into the efficacy of some alternative, yet scientific, medical remedies is in order. By Simon Campbell The organization would like to highlight the research that is being done in the world of alternative medicine. By Simon Campbell The Wistar Institute, a biomedical center with a focus on cancer research and vaccine development, has received a grant of up to $7.4 million dollars to develop a drug against cancers caused by the Epstein Barr Virus (EBV.) By Simon Campbell The CBCD has learned that researchers with the University of Utah and the University of Massachusetts have identified the first gene linked to frequent herpes-related cold sores. By Simon Campbell The Center for the Biology of Chronic Disease (CBCD) is excited to learn that the National Institute of Health (NIH) is beginning a new, large study on birth defects. By Howard Schwartz As the popularity of e-readers and e-books grows, so does the proliferation of related scams. By Simon Campbell The Center for the Biology of Chronic Disease (CBCD) is starting a public education endeavor regarding the subject of latent viruses. By Simon Campbell A committee convened by the National Academy of Sciences has released a report establishing the first set of criteria for research on chimpanzees. By Simon Campbell A major cause of school absence in children aged 11 – 16 is Chronic Fatigue Syndrome (CFS) also known as myalgic encephalitis or ME. By Simon Campbell The Society for Neuroscience reported that imaging studies showed aerobic exercise can relieve the pain typically experienced by patients with fibromyalgia (FM) who stop taking pain killing medications. By Simon Campbell Bristol-Myers Squibb is now collaborating on the development of a new Hepatitis C therapy with Tibotec Pharmaceuticals. By Simon Campbell Director of Gynecologic Cancer Prevention Research Group at UMKC, Dr. Diane Harper M.D. wrote what the CBCD believes are some very valid points regarding HPV vaccination in a guest editorial in The Daily Iowan. By Simon Campbell The Center for the Biology of Chronic Disease (CBCD) applauds Danish insulin giant, Novo Nordisk’s decision to stop using live animals in biological product control tests. By Simon Campbell A gene called C21orf91 seems to be linked with Herpes Simplex virus type 1. By Simon Campbell German researchers believe a substance found in green tea may offer an antiviral strategy to prevent Hepatitis C “reinfection." By Simon Campbell The signs and symptoms of Fibromyalgia are still not clearly defined…even today. A debate continues to rage among doctors about whether this illness is real or imagined By V tech-squad Inc. V tech-squad is launching www.antiviruscloud.net powered by McAfee Security as a Service and V tech-squad’s 24x7 voice support for consumers and SMB's. By simon An Epstein-Barr virus (EBV) vaccine in the early phases of development may prove able to prevent infectious mononucleosis and EBV-associated cancers. By Antivirus-BUYability November the 30th is international Computer Security Day. This day start way back in 1988 and is supposed to create awareness of computer related security issues. By Simon Campbell The Center for the Biology of Chronic Disease (CBCD) is watching closely the development of a new vaccine to protect against genital herpes. By Simon Campbell The Center for the Biology of Chronic Disease (CBCD) recently came across an article published on Sioux City Journal.com. The topic dealt with Fibromyalgia, which is a medical disorder, and a discussion on the ways you can manage it. Hepatitis B Vaccine Shortage in Nagpur, India Concerns the Center for the Biology of Chronic Disease By Simon Campbell The Center for the Biology of Chronic Disease (CBCD) has learned that there is a shortage of Hepatitis B (HBV) vaccine in Nagpur city, India. By Renata Privacy Protection is a rogue antivirus program that is installed to random computers with a help of Trojan viruses that are able to infiltrate infections without users’ knowledge. The program imitates being a security tool while being a scam. By Simon Campbell Although theCBCD believes that it is better to be at least 59% protected against the flu virus than to not be protected at all, the fact that the flu vaccine is not nearly as effective as previously thought is worrisome. By Simon Campbell Center for the Biology of Chronic Disease has Argued This Point for Over 8 Years By Brighton Publishing Brighton Publishing LLC announced the eBook release of debut author’s highly-anticipated, controversial bio-thriller By Simon Campbell The Center for the Biology of Chronic Disease (CBCD) has learned this week that researchers have “developed a system to “see” the source of pain (inflammation)in sufferers of Fibromyalgia. By Simon Campbell Vertex Pharmaceuticals’ new drug, “Incivek” has beaten Merck’s “Victrelis’s” sales by a gigantic margin. By Simon Campbell According to a study by the Institute of Cancer Research, testing for the presence of the human papillomavirus (HPV) as part of cervical screening reduces the number of women who don’t really need to go in for further testing by over a third. By Simon Campbell The Center for the Biology of Chronic Disease (CBCD) congratulates the success of Agneus, Inc.’s HerpV vaccine study. By Simon Campbell Bristol-Myers Squibb Co.'s new drug called BMS-790052 in combination with peginterferon and ribavirin cured up to 83% of patients infected with Hepatitis C. By Simon Campbell polyDNA, the makers of Gene-Eden-VIR, congratulates VBI Vaccines on its acquisition of Epixis, a biotechnology company that develops a new generation of Virus-Like Particle vaccines. | ||||||||||||||||||||||